{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:35:50Z","timestamp":1792427750502,"version":"4.5.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early diagnosis and intervention for chronic kidney disease (CKD) can significantly improve patient\u2019s quality of life and prognosis. Besides routine laboratory indicators and medical history, risk prediction models can predict CKD outcome. However, there is currently a lack of CKD prognostic prediction models based on transcriptomics and machine learning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Utilizing weighted correlation network analysis (WGCNA) and random forest algorithms in GSE137570, three core gene sets of different sizes were constructed, which were externally validated in GSE66494 and GSE180394, and evaluated for their predictive performance in GSE45980 by receiver operating characteristic (ROC) curves. Predictive models were built using Cox regression, LASSO regression, and logistic regression in GSE60861. And the reliability of human CKD transcriptomic analysis and the feasibility of functional studies were validated in a mouse UUO model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Combining WGCNA and differential gene analysis, 9 genes positively associated with CKD occurrence and development and 20 genes negatively associated with that were identified. By random forest algorithm, three gene sets were constructed: minimal gene set (\n                      <jats:italic>CCL2<\/jats:italic>\n                      ,\n                      <jats:italic>SUCLG1<\/jats:italic>\n                      ,\n                      <jats:italic>ACADM<\/jats:italic>\n                      ), medium gene set (\n                      <jats:italic>CCL2<\/jats:italic>\n                      ,\n                      <jats:italic>GGT6<\/jats:italic>\n                      ,\n                      <jats:italic>PCK2<\/jats:italic>\n                      ,\n                      <jats:italic>SFXN2<\/jats:italic>\n                      ,\n                      <jats:italic>SLC34A3<\/jats:italic>\n                      ,\n                      <jats:italic>ALPL<\/jats:italic>\n                      ,\n                      <jats:italic>GLTPD2<\/jats:italic>\n                      ,\n                      <jats:italic>ACADM<\/jats:italic>\n                      ,\n                      <jats:italic>SUCLG1<\/jats:italic>\n                      ), and maximal gene set (\n                      <jats:italic>CCL2<\/jats:italic>\n                      ,\n                      <jats:italic>MMP7<\/jats:italic>\n                      ,\n                      <jats:italic>GGT6<\/jats:italic>\n                      ,\n                      <jats:italic>PCK2<\/jats:italic>\n                      ,\n                      <jats:italic>SFXN2<\/jats:italic>\n                      ,\n                      <jats:italic>SLC34A3<\/jats:italic>\n                      ,\n                      <jats:italic>ALPL<\/jats:italic>\n                      ,\n                      <jats:italic>GLTPD2<\/jats:italic>\n                      ,\n                      <jats:italic>ACADM<\/jats:italic>\n                      ,\n                      <jats:italic>SUCLG1<\/jats:italic>\n                      ). In external validation, the maximal plage score had best classification performance for CKD (AUC:0.767) in GSE66494 and in GSE180394 (AUC:0.760), the medium plage score achieved a predictive performance for CKD progression (AUC = 0.758) in GSE45980. In the multivariate model, Cox regression analysis constructed a risk model with only minimal z-score, further LASSO regression analysis included gender and minimal z-score, but logistic regression multivariate analysis failed to be constructed with any score. A high degree of similarity between mouse CKD and human CKD in KEGG enrichment was observed in the mouse unilateral ureteral obstruction model, and the core genes related to the occurrence and progression of human CKD remained diagnostically valuable in mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides a transcriptomics-based risk prediction model for the occurrence and development of CKD based on machine learning, offering potential target genes for the further experimental research of CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2025.1627355","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T13:01:51Z","timestamp":1755262911000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of progression-related genes and construction of prognostic model for chronic kidney disease by machine learning"],"prefix":"10.3389","volume":"13","author":[{"given":"Bingkun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12649","DOI":"10.3390\/ijerph182312649","article-title":"Validation of a novel predictive algorithm for kidney failure in patients suffering from chronic kidney disease: the prognostic reasoning system for chronic kidney disease (PROGRES-CKD)","volume":"18","author":"Bellocchio","year":"2021","journal-title":"International J. Environ. Res. Public Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"W317","DOI":"10.1093\/nar\/gkab447","article-title":"KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis","volume":"49","author":"Bu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1681\/asn.0000000000000195","article-title":"Erythrocyte ENT1-AMPD3 axis is an essential purinergic hypoxia sensor and energy regulator combating CKD in a mouse model","volume":"34","author":"Chen","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1002\/imt2.239","article-title":"ImageGP 2 for enhanced data visualization and reproducible analysis in biomedical research","volume":"3","author":"Chen","year":"2024","journal-title":"Imeta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"104489","DOI":"10.1016\/j.ebiom.2023.104489","article-title":"Identifying subtypes of chronic kidney disease with machine learning: development, internal validation and prognostic validation using linked electronic health records in 350,067 individuals","volume":"89","author":"Dashtban","year":"2023","journal-title":"Ebiomedicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"E307","DOI":"10.1016\/S2214-109x(16)00071-1","article-title":"Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study","volume":"4","author":"Ene-Iordache","year":"2016","journal-title":"Lancet Glob. Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.ekir.2022.05.004","article-title":"Development and external validation of a machine learning model for progression of CKD","volume":"7","author":"Ferguson","year":"2022","journal-title":"Kidney International Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"148724","DOI":"10.1016\/j.gene.2024.148724","article-title":"T2DM\/CKD genetic risk scores and the progression of diabetic kidney disease in T2DM subjects","volume":"927","author":"Galuska","year":"2024","journal-title":"Gene"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e33705","DOI":"10.1097\/md.0000000000033705","article-title":"Bioinformatics analysis reveals CCR7 as a potential biomarker for predicting CKD progression","volume":"103","author":"Lai","year":"2024","journal-title":"Med. Baltim."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1002\/imt2.85","article-title":"OmicStudio: a composable bioinformatics cloud platform with real-time feedback that can generate high-quality graphs for publication","volume":"2","author":"Lyu","year":"2023","journal-title":"Imeta"},{"key":"B12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/ijms23010336","article-title":"OMICS in chronic kidney disease: focus on prognosis and prediction","volume":"23","author":"Provenzano","year":"2022","journal-title":"International J. Mol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e139927","DOI":"10.1172\/JCI139927","article-title":"Biomarkers of inflammation and repair in kidney disease progression","volume":"131","author":"Puthumana","year":"2021","journal-title":"J. Clin. Investigation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.kint.2024.01.012","article-title":"Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine","volume":"105","author":"Reznichenko","year":"2024","journal-title":"Kidney International"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1681\/Asn.2012101006","article-title":"A combined epidemiologic and metabolomic approach improves CKD prediction","volume":"24","author":"Rhee","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/eci.12585","article-title":"Renal microRNA- and RNA-Profiles in progressive chronic kidney disease","volume":"46","author":"Rudnicki","year":"2016","journal-title":"Eur. J. Clin. Investigation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s40620-023-01609-9","article-title":"Predict, diagnose, and treat chronic kidney disease with machine learning: a systematic literature review","volume":"36","author":"Sanmarchi","year":"2023","journal-title":"J. Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1681\/Asn.2014050423","article-title":"Diagnosis and prediction of CKD progression by assessment of urinary peptides","volume":"26","author":"Schanstra","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1590\/2175-8239-Jbn-2021-0030","article-title":"Renin angiotensin system molecules and chemokine (C-C motif) ligand 2 (CCL2) in chronic kidney disease patients","volume":"44","author":"Schettini","year":"2022","journal-title":"J. Bras. De. Nefrol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1038\/s44318-024-00101-9","article-title":"SUCLG1 restricts POLRMT succinylation to enhance mitochondrial biogenesis and leukemia progression","volume":"43","author":"Yan","year":"2024","journal-title":"Embo J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6567","DOI":"10.1038\/s41598-025-89733-3","article-title":"Machine learning selection of basement membrane-associated genes and development of a predictive model for kidney fibrosis","volume":"15","author":"Yuan","year":"2025","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/j.ajkd.2021.05.018","article-title":"A predictive model for progression of CKD to kidney failure based on routine laboratory tests","volume":"79","author":"Zacharias","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/biom15040498","article-title":"Integration of DNA methylome and transcriptome analysis to identify novel epigenetic targets in the acute kidney injury-chronic kidney disease transition","volume":"15","author":"Zheng","year":"2025","journal-title":"Biomolecules"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1627355\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T13:01:52Z","timestamp":1755262912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1627355\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":24,"alternative-id":["10.3389\/fcell.2025.1627355"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1627355","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"article-number":"1627355"}}